Mosaic ImmunoEngineering (CPMV) Gross Profit (2010 - 2011)
Mosaic ImmunoEngineering (CPMV) posted quarterly Gross Profit of $35274.0 for Q4 2011, up 3266.43% year-over-year from $1047.8 in Q4 2010, and down 65.24% quarter-over-quarter from $101479.0 in Q3 2011.
Mosaic ImmunoEngineering (CPMV) Gross Profit (2010 - 2011) Analysis & Trends
Mosaic ImmunoEngineering's Gross Profit history runs 2 years deep, the most recent figure standing at $35274.0 for Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2011 | 35,274.00 |
| Nov 30, 2011 | 35,274.00 |
| Aug 31, 2011 | 101,479.00 |
| Aug 31, 2011 | 101,479.00 |
| Nov 30, 2010 | -1,114.00 |
| Nov 30, 2010 | -1,114.00 |
| Aug 31, 2010 | 1,751.00 |
| Aug 31, 2010 | 1,751.00 |